Giant Cell Arteritis in Dependency of Elderly
Conditions
Keywords
Giant Cell Arteritis, Dependency, Elderly
Brief summary
Giant cell arteritis is the leading cause of vasculitis in the elderly. No work evaluates its impact on autonomy. At the diagnosis a gerontological evaluation will be carried out including the scores ADL, iADL, MNA, SF 36, SPPB, FRIED and GDS. A monthly telephone reassessment will collect ADL and iADL. The end-of-study consultation at M12, conducted by a geriatrician, will have the same scores as at M0. This will make it possible to evaluate the difference in the functional autonomy score between M0 and M12 in the elderly with ACG.
Interventions
OTHERAssessment by questionnaire
At diagnosis a gerontological evaluation will be carried out including the following tests: ADL, iADL, MNA, SF 36, SPPB, FRIED criteria and GDS. The set of scales and scores of the procedure is commonly used in geriatrics to assess the fragility of the patient. A monthly telephone reassessment conducted by an ARC will collect ADL and iADL from the first month to the eleventh month. The end-of-study consultation will be conducted by a geriatrician at the 12th month and will include the following tests: ADL, iADL, MNA, SF 36, the SPPB, the criteria of FRIED and the GDS
Sponsors
University Hospital, Limoges
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age greater than or equal to 65 years with at least 2 comorbidities \* present, or age greater than or equal to 75 years * Diagnosis of ACG meeting the diagnostic criteria of ACG 1990 ACR * comorbidity = chronic pathology
Exclusion criteria
* Neoplastic pathology under treatment * Brain pathology with motor disability * Dementia at a severe stage (MMS \<22/30) * Unable to answer the phone * Participation in a therapeutic clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Activities of Daily Living (ADL) | Month 12 | Compare score between Month 0 and Month 12. The scale is evaluated from 0 (dependence) to 6 (autonomy). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Activities of Daily Living (ADL) | Month 11 | Compare the evolution every month at M0 and every month up to Month 11 The scale is evaluated from 0 (dependence) to 6 (autonomy). |
Other
| Measure | Time frame | Description |
|---|---|---|
| The Short Form Health Survey (SF-36) : Physical score | Month 12 | Compare score between Month 0 and Month 12 The scale is evaluated from 13,6 (poor physical condition) to 61.9 (good physical condition) |
| The Short Form Health Survey (SF-36) : Psychic score | Month 12 | Compare score between Month 0 and Month 12 The scale is evaluated from 15.6 (poor psychic condition) to 70 (good physical condition) |
| Short Physical Performans Battery (SPPB) | Month 12 | compare score between Month 0 and Month 12 The scale is evaluated from 0 (poor performance) to 12 (high performance) |
| Instrumental Activities of Daily Living (iADL) | Month 12 | Compare the evolution every month at Month 0 and every month up to Month 12 The scale is evaluated from 0 (dependence) to 8 (autonomy). |
| Geriatric Depression Scale (GDS) | Month 12 | compare score between Month 0 and Month 12 The scale is evaluated from 0 (normal) to 30 (severe depression) |
| The cumulative dose of corticosteroids and autonony loss | Month 12 | — |
| fragility criteria questionnaire (Fried) | Month 12 | compare score between Month 0 and Month 12 The scale is evaluated from 0 (robust) to 5 (fragile) |
| Mini Nutritional Assessment (MNA) | Month 12 | Compare score between Month 0 and Month 12 The scale is evaluated from 0 (poor nutritional status) to 30 (correct) |
Countries
France
Outcome results
None listed